Does ENZALUTAMIDE Cause Dyspepsia? 268 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 268 reports of Dyspepsia have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.5% of all adverse event reports for ENZALUTAMIDE.
268
Reports of Dyspepsia with ENZALUTAMIDE
0.5%
of all ENZALUTAMIDE reports
18
Deaths
45
Hospitalizations
How Dangerous Is Dyspepsia From ENZALUTAMIDE?
Of the 268 reports, 18 (6.7%) resulted in death, 45 (16.8%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Dyspepsia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 268 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Dyspepsia?
ADALIMUMAB (3,586)
METHOTREXATE (2,690)
RITUXIMAB (2,289)
TOFACITINIB (2,264)
PREDNISONE (2,224)
APREMILAST (2,207)
ETANERCEPT (2,100)
ESOMEPRAZOLE (2,064)
TOCILIZUMAB (2,046)
LEFLUNOMIDE (1,981)
Which ENZALUTAMIDE Alternatives Have Lower Dyspepsia Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE